Synthesis and characterization of new materials based on metal nanoparticles applied to the transportation of medicines, study of intra-aggregated bile salt mobility and hydrogen production
One important point of this project will be the visit of foreign researchers to UFMS during short time, which will teach special courses in English. In addition, the project will promote the mobility of teachers and students as well as publications with a high impact factor, and the probable registrable technological innovations that will be produced involving teachers and students from UFMS and researchers of the foreign partner universities. A first thematic is the preparation and characterization of new materials based on carbon and non-noble metals, luminescent coordination compounds based on transition metals, which may have potential applicability in the area of electroluminescent materials, technological devices such as LEDs, sensors, new electrochemical catalysts, batteries, etc. This project also involves the synthesis of gold and silver nanoparticles in the complex aqueous systems that are often found for applications in biological systems as well as understanding the mobility of small molecules or nanoparticles in the confined and compartmentalized spaces in the manometer scale; these nanoparticles with gadolinium complexes can act as multifunctional contrasts in diagnostic imaging techniques as an alternative to contrast agents for computed tomography (CT) and magnetic resonance imaging (MRI). Due to the high X-ray attenuation coefficient and increased circulation time in the body, these nanoparticles decrease the dose administered to the patient and the likelihood of adverse effects. Also, nitrogen (or sulphur) metallic nanostructures (nanocomposites) of Ni x M 1-x N (and/or S) (where M = Co, Fe, Cu, W, and Mo) will be synthesized (coated or not with a thin layer of Pt) supported on carbon material (graphene oxide nanoribbons or graphene nanoribbons), applying these nanocomposites as electrocatalysts for HER and OER.